The UK Serious Fraud Office (SFO) said on Thursday it expects to decide next year whether it will file criminal charges in bribery investigations related to drugs giant GlaxoSmithKline and aero engine company Rolls-Royce .
The SFO launched an investigation into GSK and its subsidiaries in 2014. Britain’s biggest drugmaker has already been fined a record 3 billion yuan (US$452 million) by Chinese authorities for paying bribes to doctors to use its drugs.
The SFO’s continued investigation into Rolls-Royce is focusing on individuals after Rolls-Royce paid 671 million pounds (US$870 million) in January to settle British, U.S. and Brazilian bribery investigations.
This article has been summarised, the full original article can be found at channelnewsasia.com